Related Experiment Videos

[Kinetic peculiarities of the immunodepressive effect of methotrexate]

Farmakologiia I Toksikologiia
|January 1, 1976
PubMed

Insights

Methotrexate administration alters plaque-forming cell (PFC) dynamics in mice. This study observed rapid, undulating changes in spleen PFC counts following methotrexate treatment, suggesting a novel immune response mechanism.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Methotrexate is an immunosuppressive drug.
  • Understanding its impact on immune cell dynamics is crucial.

Purpose of the Study:

  • To investigate the effect of methotrexate on plaque-forming cell (PFC) kinetics.
  • To analyze the temporal changes in spleen PFCs after methotrexate administration.

Main Methods:

  • Mice were immunized with sheep erythrocytes.
  • Methotrexate (2.5 mg/kg) was administered at 48 or 72 hours post-immunization.
  • Spleen PFC counts were measured every 4 hours for 68 hours.

Main Results:

  • Methotrexate induced rapid, undulating fluctuations in spleen PFC counts.
  • The observed changes in PFC numbers showed rapid doubling and decline periods (2-4 hours).
  • These dynamics were consistent regardless of methotrexate administration timing (48h vs. 72h).

Conclusions:

  • Methotrexate appears to trigger synchronous recruitment of antigen-activated precursor cells.
  • The rapid decline in PFCs may be due to cell destruction via "unbalanced growth".

Related Concept Videos